Contact Us:
14 Bonhill Street
London EC2A 4BX
Tel: +44 (0)8450 546 500
Foviance and Applied Works appointed to deliver global user experience for AstraZeneca
Wednesday 8th August 2007
Foviance, the expert in online experience management, and Applied Works, a graphic design consultancy, have been appointed to carry out a User Centred Design (UCD) project for international pharmaceutical company, AstraZeneca.
The project is part of AstraZeneca's continuous website improvement, which has already been recognised for its effectiveness by The FT Bowen Craggs corporate websites index, placing AstraZeneca as the top pharmaceutical organisation, and fifth overall. The project will involve a global review of all corporate and product branded websites, which will then be used to prepare a comprehensive set of website guidelines to inform the design of all new AstraZeneca websites worldwide.
Foviance believes strongly that website usability should not compromise design, and so will work closely in partnership with Applied Works, AstraZeneca’s creative agency and brand guardians, to design and certify the recommended layouts. This will ensure that the final specifications adhere to both usability and creative guidelines.
The research process will include evaluation of prototype websites, which will be tested using participants drawn from the corporate, healthcare professional and patient audiences that frequent AstraZeneca's sites. This sample audience will then be assessed using eye-tracking tests, establishing their ability to carry out predefined user tasks, which will provide vital real world data for the final guidelines.
Sally Shackleton, corporate communications director for AstraZeneca, comments: "AstraZeneca's reputation is driven by the experiences of our stakeholders, and it is always our goal to continually improve any point of contact. This is especially important online, where our websites act as our window to the world. We will be working with Foviance and Applied to review and improve our online customer experience, which will then be integrated into our web presence worldwide."
Paul Blunden, CEO of Foviance, adds: "AstraZeneca has put users first by investing in customer experience. It is important to strike a balance between simplifying the user’s journey, taking into consideration cultural and language issues, while still facilitating the expression of brand values and creativity. This is why working closely with AstraZeneca's creative and branding agency, Applied Works, was so important."
News
07/07/2008
WebAbacus unveils new 'Single-Click' interface in latest web analytics tool
27/06/2008
Around the world in 80 conferences - Catriona and Paul's international education programme
22/04/2008
Foviance launch new service at the Omniture Summit 2008
18/03/2008
Foviance and RXP release cross-channel research - get the white paper here
19/02/2008
Foviance appoints two new consultants to its usability team
12/02/2008
ITV selects WebAbacus to track streaming media success
25/11/2007
Foviance founder one of Britain's 500 rising stars
13/11/2007
Foviance scopes out online audience for publisher Egmont
02/10/2007
bmi partners with Foviance to launch new and improved website
18/09/2007
Foviance appoints four new consultants to its usability team
21/08/2007
Foviance welcomes back WebAbacus founder James Andrews
08/08/2007
Foviance and Applied Works appointed to deliver global user experience for AstraZeneca
28/06/2007
Foviance wheels in Philip Hunt as Chairman
01/05/2007
Foviance announces partnership with Keynote Systems
22/03/2007
Sage tracks online customer journey with Foviance
Careers
14/11/2006
Usability Consultants




